First Diabetic Retinopathy Prevalence Study in Portugal: RETINODIAB Study-Evaluation of the Screening Programme for Lisbon and Tagus Valley Region

Autor: Ana Luísa Papoila, Edgar Mesquita, Victor Genro, João Filipe Raposo, Marco Dutra Medeiros
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Adult
Male
medicine.medical_specialty
Pediatrics
Time Factors
Cross-sectional study
Prevalence
030209 endocrinology & metabolism
Type 2 diabetes
Diabetic Retinopathy/etiology
Diabetic Retinopathy/epidemiology
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Mass Screening/methods
Risk Factors
Ophthalmology
Epidemiology
medicine
Humans
Mass Screening
Mass screening
Aged
Retrospective Studies
Diabetic Retinopathy
Portugal
business.industry
Diabetes Mellitus
Type 2/complications

Retrospective cohort study
Diabetic retinopathy
Middle Aged
medicine.disease
Diabetic Retinopathy/diagnosis
Sensory Systems
3. Good health
CHLC OFT
Cross-Sectional Studies
Diabetes Mellitus
Type 2

030221 ophthalmology & optometry
Portugal/epidemiology
Female
business
Retinopathy
Follow-Up Studies
Zdroj: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Popis: Background/aims In Portugal, so far, there is no study or even accurate data on the prevalence of diabetic retinopathy (DR), based on a large representative sample and on a long-term follow-up. The objective of our study was to determine the prevalence of DR based on a national screening community-based programme. Methods A 5-year retrospective analysis of the RETINODIAB screening programme results was implemented in Lisbon and Tagus Valley area between July 2009 and October 2014. We estimated the prevalence of retinopathy for all patients with type 2 diabetes and studied the association between known risk factors and retinopathy emergence at their first screening. Results Throughout this period, from a total of 103 102 DR readable screening examinations, 52 739 corresponded to patients who attended RETINODIAB screening at entry. Globally, DR was detected in 8584 patients (16.3%). Of these, 5484 patients (10.4%) had mild non-proliferative (NP) DR, 1457 patients (2.8%) had moderate NPDR and 672 (1.3%) had severe NPDR. Finally, 971 patients (1.8%) had proliferative DR requiring urgent referral to an ophthalmologist. The presence of any DR, non-referable DR or referable DR was strongly associated with increasing duration of diabetes and earlier age at diagnosis. Conclusions The prevalence rate of DR in our study (16.3%) was slightly lower than other published international data. The RETINODIAB network proved to be an effective screening programme as it improved DR screening in Lisbon and Tagus Valley surrounding area.
Databáze: OpenAIRE